Does TECLISTAMAB Cause C-reactive protein increased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of C-reactive protein increased have been filed in association with TECLISTAMAB (TECVAYLI). This represents 0.4% of all adverse event reports for TECLISTAMAB.
5
Reports of C-reactive protein increased with TECLISTAMAB
0.4%
of all TECLISTAMAB reports
1
Deaths
2
Hospitalizations
How Dangerous Is C-reactive protein increased From TECLISTAMAB?
Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB Cause?
Cytokine release syndrome (257)
Pneumonia (101)
Plasma cell myeloma (100)
Immune effector cell-associated neurotoxicity syndrome (99)
Pyrexia (86)
Covid-19 (82)
Infection (58)
Drug ineffective (52)
Neutropenia (48)
Sepsis (48)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which TECLISTAMAB Alternatives Have Lower C-reactive protein increased Risk?
TECLISTAMAB vs TECLISTAMAB-CQYV
TECLISTAMAB vs TEDIZOLID
TECLISTAMAB vs TEDUGLUTIDE
TECLISTAMAB vs TEDUGLUTIDE\WATER
TECLISTAMAB vs TEGAFUR